The role of nasal mucus in upper airways function

Pediatric Nasal and Sinus Disorders

Volumn , Issue , 2005, Pages 19-58

  Henkin, Robert I ^a   Doherty, Amy ^b,c   Martin, Brian M ^b  

^a Center for Molecular Nutrition and Sensory Disorders   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883251647     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (173)

1. McMartin CL, Hutchinson EF, Hyde R, Peters GE. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci 1987; 76:525-540.
2. Boucher RC. Chemical modulation of airway epithelial permeability. Environ Health Perspect 1980; 53:3-12.
3. Cremaschi D, Rosetti C, Draghetti MT, Manzoni C, Alberti V. Active transport of polypeptides in rabbit nasal mucosa: possible role in the sampling of potential antigens. Pflugers Arch 1991; 419:425-432.
4. Cremaschi D, Porta C, Ghirardelli R. Endocytosis of polypeptides in rabbit nasal respiratory mucosa. News Physiol Sci 1997; 12:219-225.
5. Jeffrey PK. Structural, immunologic and neural elements of the normal human airway wall. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Cambridge, MA: Blackwell, 1995:80.
6. Cole P. Modification of inspired air. In: Mathew OP, Sant’Ambroglio G, eds. Lung Biology in Health and Disease. Vol. 35. New York: Marcel Dekker, 1988:415-445.
7. Gray H. Anatomy of the Human Body. Philadelphia, PA: Lea and Febriger, 1954:1198-1202.
8. Davies RJ, Devalia JL. Epithelial cell dysfunction in rhinitis. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Cambridge, MA: Blackwell, 1995:612.
9. Jeffery PK. Morphologic features of airway surface epithelial cells and glands. Am Rev Respir Dis 1983; 128:514-520.
10. Verdugo P. Goblet cell secretion and mucogenesis. Am Rev Physiol 1990; 52:157-176.
11. Hyams VJ. Pathology of the nose and paranasal sinuses. In: English GM, ed. Otolaryngology. Vol. 2. Philadelphia, PA: Lippincott, 1986:1-95.
12. Blenkinsopp WK. Proliferation of respiratory tract epithelium in the rat. Exp Cell Res 1967; 46:114-154.
13. Evans MJ, Plopper CG. The role of basal cells in adhesion of columnar epithelium to airway basement membrane. Am Rev Respir Dis 1988; 138:481-483.
14. Takizawa H, Romberger D, Beckmann J et al. Separation of bovine bronchial epithelial cell subpopulations by density centrifugations: a method to isolate ciliated and non-ciliated cell fractions. Am J Respir Cell Mol Biol 1990; 3:553-562.
15. Carson JL, Collier AM, Boucher RC. Ultrastructure of the respiratory epithelium in the human nose. In: Mygind N, Pitcorn U, eds. Allergic and Vasomotor Rhinitis:Pathophysiological Aspects. Copenhagen: Munksgaard, 1987:11-27.
16. Evans MJ, Cabral-Anderson LJ, Freeman G. Role of the Clara cell in renewal of bronchiolar epithelium. Lab Invest 1978; 38:648-655.
17. Ash JE, Raum M. An Atlas of Otolaryngic Pathology. Armed Forces Institute of Pathology. Washington, DC: US Government Printing Office, 1956.
18. Goldstein BJ, Fang H, Youngentob SL, Schwob JE. Transplantation of multipotent progenitors from the adult olfactory epithelium. Neuroreport 1998; 9:1611-1617.
19. Schwob JE, Huard JMT, Luskin MB, Youngentob SL. Retroviral lineage studies of the rat olfactory epithelium. Chem Senses 1994; 19:671-672.
20. Huard JMT, Schwob JE. Cell cycle of globose basal cells in rat olfactory epithelium. Dev Dyn 1995; 203:17-26.
21. Ayers M, Jeffrey PK. Proliferation and differentiation in adult mammalian airways epithelium: a review. Eur Respir J 1988; 1:58-80.
22. Widdicome JH. Structure and function of epithelial cells in controlling airway lining fluid. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Cambridge, MA: Blackwell, 1995:565.
23. Baraniuk JN, Kaliner MA. Functional activity of upper airway nerves. In:Busse WW, Holgate ST, eds. Asthma and Rhinitis. Cambridge, MA: Blackwell, 1995:652.
24. Lucas AM, Douglas LC. Principles underlying ciliary activity in the respiratory tract. II. A comparison of nasal clearance in man, monkey and other mammals. Arch Otolaryngol 1934; 20:518-541.
25. Sanderson MJ, Sleigh MA. Ciliary activity of cultured rabbit tracheal epithelium:beat pattern and metachromy. J Cell Sci 1981; 47:331-347.
26. Yomeda K. Mucous blanket of rat bronchus: ultrastructural study. Am Rev Respir Dis 1976; 114:837-842.
27. Havez R, Rousel P. Bronchial mucus: physical and biochemical features. In:Weiss EB, Segal MS, eds. Bronchial Asthma: Mechanisms and Therepeutics. Boston, MA: Little Brown, 1976:409-422.
28. Doherty AE, Martin BM, Dai WL, Henkin RI. Carbonic anhydrase (CA) activity in nasal mucus appears to be a marker for loss of smell (hyposmia) in humans. J Invest Med 1997; 45:237A.
29. Swiss Protein Data Base-PC Gene (Release 14), 1999.
30. Meret S, Henkin RI. Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem 1971; 17:369-373.
31. Boekhoff I, Braunewell KH, Andreini I, Breer H, Gundelfinger E. The calciumbinding protein VILIP in olfactory neurons: regulation of secondary messenger signaling. Eur J Cell Biol 1997; 72:151-158.
32. Bastianelli E, Polans AS, Hidaka H, Pochet R. Differential distribution of six calcium-binding proteins in the rat olfactory epithelium during post natal development and adulthood. J Comp Neurol 1995; 354:395-409.
33. Fujiwara M, Nakamura H, Kawasaki M, Nakano Y, Kuwano R. Expressions of a calcium-binding protein (spot 35/calbindin-D28K) in mouse olfactory cells: possible relationship to neuronal differentiation. Eur Arch Otorhinolarygol 1997; 254:105-109.
34. Smith RP, Shellard R, Dhillon DP, Winter J, Mehta A. Asymmetric interactions between phosphorylation pathways regulating ciliary beat frequency in human nasal respiratory epithelium in vitro. J Physiol (Lond) 1996; 496:883-889.
35. Iino S, Kobayashi S, Okazaki K, Hidaka H. Neurocalcin-immunoreactive receptor cells in the rat olfactory epithelium and vomeronasal organ. Neurosci Lett 1995; 191:91-94.
36. Richli EE, Ghazanafar AS, Gibbons BH, Edsall JT. Carbonic anhydrases from human erythrocytes. J Biol Chem 1964; 239:1065-1078.
37. Raphael GD, Baraniuk JN, Kaliner MA. How and why the nose runs. J Allergy Clin Immunol 1991; 87:457-491.
38. Klockars M, Reitano S. Tissue distribution of lysozyme in man. J Histochem Cytochem 1975; 23:932-940.
39. Raphael GD, Jeney EV, Baraniuk JN, Kim I, Meredith SD, Kaliner MA. The pathophysiology of rhinitis: lactoferrin and lysozyme in nasal secretions. J Clin Invest 1989; 84:1528-1535.
40. Lindahl M, Ståhlbom Tagesson C. Two dimensional gel electrophoresis of nasal and bronchoalveolar lavage fluid after occupational exposure. Electrophoresis 1995; 16:1199-1204.
41. Peden DB, Hohman R, Brown ME, Mason RT, Berkebile C, Fales HM, Kaliner MA. Uric acid is a major antioxidant in human nasal airways secretions. Proc Natl Acad Sci USA 1990; 87:7638-7642.
42. Imada M, Iwamoto J, Nonaka S, Kobayashi Y, Unno T. Measurement of nitric oxide in human nasal airways. Eur Respir J 1996; 9:556-559.
43. Hegnhj Schaffalitsky de Muckadell OB. An enzyme-linked immunosorbent assay for measurement of lactoferrin in duodenal aspirates and other biological fluids. Scand J Clin Lab Invest 1985; 45:489-495.
44. Rossen RD, Schade AL, Butler WT, Kasel JA. The proteins in nasal secretion: a longitudinal study of the gA-globulin, g G-globulin, albumin, siderophilin and total protein in nasal washings from adult male volunteers. J Clin Invest 1966; 45:768-776.
45. Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Lond B Biol Sci 1922; 93:306-317.
46. Raphael GD, Igarashi Y, White MV, Kaliner MA. The pathophysiology of rhinitis V. Sources of proteins in allergen-induced nasal secretions. J Allergy Clin Immunol 1991; 88:33-42.
47. Sümuller U, Arnhold M, Fritz H, Wiedenmann K, Machleidt W, Heinzel R, Appelhaus H, Gassen HG, Lottspeich F. The acid stable proteinase inhibitor of human mucous secretions (HUSI-1 antileukoprotease). FEBS Lett 1986; 199:43-48.
48. Lee CH, Igarash Y, Hohman RJ, Kaulbach H, White MV, Kaliner MA. Distribution of secretory leukoprotease inhibitor in the human nasal airway. Am Rev Respir Dis 1993; 147:710-716.
49. Stetler G, Brewer MT, Thompson RC. Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res 1986; 14:7883-7896.
50. Umland TC, Swaminathan S, Singh G, Warty V, Furey W, Platcher J, Sax M. Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 A ° resolution. Nat Struct Biol 1994; 1:538-549.
51. Singh G, Katyah SL, Brown WE, Phillips S, Kennedy AL, Anthony J, Squeglia N. Amino acid and cDNA nucleotide sequence of human Clara cell 10 kDa protein. Biochim Biophys Acta 1988; 950:329-337.
52. Boyd MR. Evidence for the Clara cell as a site of cytochrome P 450-dependent mixed-function oxidase in lung. Nature 1977; 269:713-715.
53. Mornon JP, Fridlansky F, Bally R, Milgrom E. X-ray crystallographic analyses of a progesterone-binding protein: the c222 crystal form of oxidized interoglobin at 2.2 A ° resolution. J Mol Biol 1980; 137:415-429.
54. Morgenstern JP, Griffith IJ, Brauer AW, Rogers BL, Bond JF, Chapman MD, Kuo MC. Amino acid sequence of Fel dI, the major allergen of the domestic cat:protein sequence analysis and cDNA cloning. Proc Natl Acad Sci USA 1991; 88:9690-9694.
55. Matulionis DH, Parks HF. Ultrastructural morphology of the normal nasal respiratory epithelium of the mouse. Anat Rec 1973; 176:65-84.
56. Schlesinger DH, Hay DI. Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits phosphate precepitation from human parotid saliva. J Biol Chem 1977; 252:1689-1695.
57. Hay DI. The interaction of human parotid salivary proteins with hydroxyapatite. Arch Oral Biol 1973; 18:1517-1529.
58. Gron P. The demonstration of a dicalcium phosphate stabilizing factor in saliva. Arch Oral Biol 1973; 18:1379-1383.
59. Goodfellow PN, Jones EA, VanHeyningen V et al. The b2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature (Lond) 1975; 254:267-269.
60. Lawlor DA, Warren E, Ward FE, Parham P. Comparison of class 1 MHC alleles in humans and apes. Part II. Immunol Rev 1990; 114:127-132.
61. Mavlight GM, Stuckey SE, Cabinillas FF et al. Diagnosis of leukemia or lymphoma in the central nervous system by beta2-microglobulin determination. New Engl J Med 1980; 303:718-722.
62. Güssow D, Rein R, Ginjaar I, Hochstenback F, Seeman G, Kottman A, Ploegh HL. The human b2-microglobulin gene. Primary structure and definition of the transcriptional unit. Part I. J Immunol 1987; 139:3132-3138.
63. Groves ML, Greenberg R. Complete amino acid sequence of bovine b2-microglobulin. J Biol Chem 1982; 257:2619-2626.
64. Araki T, Gejyo F, Takagi K, Haupt H, Schwick HG, Bürge W, Marti T, Schaller J, Rickli E, Bussmer R, Atkinson PH, Putnan FW, Schmid K. Complete amino acid sequence of human plasma Zn-a2-glycoprotein and its homology to histocompatability antigens. J Immunol 1988; 85:679-683.
65. Klein J. In: Quastel MR, ed. Cell Biology and Immunobiology of Leukocyte Function. New York: Academic Press, 1979:309-314.
66. Barnstable CJ, Jones EA, Bodmer WF, Bodmer JG, Arce-Gomez B, Smary D, Crompton M. Genetics and serology of HL-A linked human Ia antigens. Cold Spring Harbor Symp Quant Biol 1976; 41:443-455.
67. Plesner T. Immunochemical studies of human b2-microglobulin. Allergy 1980; 35:627-637.
68. Michalski JP, Daniels TE, Talal N, Gray HM. Beta2 microglobulin and lymphocytic infiltration in Sjögren’s syndrome. New Engl J Med 1975; 293:1228-1231.
69. Gates FT, Coligan JE, Kindt TJ. Complete amino acid sequence of rabbit b2- microglobulin. Biochemistry 1979; 18:2267-2272.
70. Klein J. The major histocompatability complex of the mouse. Science 1979; 203:516-521.
71. Goding JW, Walker ID. Allelic forms of b2-microglobulin in the mouse. Proc Natl Acad Sci USA 1980; 77:7395-7399.
72. Unanue ER, Beller DI, Lu CY, Allen PM. Antigen presentation: comments on its regulation and mechanism. J Immunol 1984; 132:1-5.
73. Marrack P, Kappler J. The T cell receptor. Science 1987; 238:1073-1079.
74. Peterson PA, Cunningham BA, Berggard I, Edelman GM. b2-microglobulin-a free immunoglobulin domain contains an intrachain disulfide loop of 57 residues similar in size to that found in IgG. Proc Natl Acad Sci USA 1972; 69:1697-1701.
75. Wang D, Levasseur-Acker GM, Janowski R, Kanny G, Moneret-Vantrin DA, Charron D, Lockhart A, Swierczeski E. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon. Clin Exp Allergy 1997; 27:306-314.
76. Lawler DA, Warren E, Ward FE, Parham P. Comparison of class I MHC alleles in humans and apes. Part I. Immunol Rev 1990; 113:147-185.
77. Alam R, Sim TS, Hilsmeier K, Grant JA. Development of a new technique for recovery of cytokines from inflammatory sites in situ. J Immunol Methods 1992; 155:25-29.
78. Lindberg K, Rynnel-Dagoo M, Sundquist KG. Cytokines in nasopharyngeal secretions: evidence for defective IL-1b production in children with recurrent episodes of acute otitis media. Clin Exp Immunol 1994; 97:396-402.
79. Baumgarten CR, Nichols RC, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Plasma kallikrein during experimentally induced allergic rhinitis: role to kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol 1986; 137:977-982.
80. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MS. Substance P, calcitonin gene-related peptide and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993; 92:95-104.
81. Johnson CW, Larivee P, Shelhamer JH. Epithelial cells: regulation of mucus secretion. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Cambridge, MA: Blackwell, 1995:584-598.
82. Balkwill F, Burke F. The cytokine network. Immunol Today 1989; 10:299-304.
83. Proud D, Gwaltney JMJ, Hendley O, Dinorello CA, Gillis S, Schleiner RP. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994; 169:1007-1013.
84. Diaz-Sanchez D, Tsien A, Casillos A, Dotson AR, Saxon A. Enhanced nasal cytokine production in human lungs after in-vivo challenge with diesel exhaust particulates. J Allergy Clin Immunol 1996; 98:114-123.
85. Kenny JS, Baker C, Welch MR, Altman LC. Synthesis of interleukin-1a, interleukin-6 and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol 1994; 93:1060-1070.
86. Henkin RI, Lippoldt RE, Bilstad J, Edelhoch H. A zinc protein isolated from human parotid saliva. Proc Natl Acad Sci USA 1975; 72:488-492.
87. Henkin RI, Lippoldt RE, Bilstad J, Wolf RO, Lum CKL, Edelhoch R. Fractionation of human parotid saliva. J Biol Chem 1978; 253:7556-7565.
88. Henkin RI, Martin BM, Agarwal RP. Carbonic anhydrase VI deficiency: a viral induced enzyme disorder amenable to treatment with exogenous zinc. J Invest Med 1995; 43:242A.
89. Henkin RI, Martin BM, Agarwal RP. Efficacy of exogenous zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci 1999; 318:392-404.
90. Henkin RI, Martin BM, Agarwal RP. Decreased parotid saliva gustin/carbonic anhydrase VI secretion: an enzyme disorder manifested by gustatory and olfactory dysfunction. Am J Med Sci 1999; 318:380-391.
91. Thatcher B, Doherty AE, Orvisky E, Martin BM, Henkin RI. Gustin from human parotid saliva is carbonic anhydrase (CA) VI. Biochem Biophys Res Commun 1998; 250:635-641.
92. Henkin RI. Zinc, saliva and taste: interrelationships of gustin, nerve growth factor, saliva and zinc. In: Hambidge KM, Nichols BL, eds. Zinc and Copper in Clinical Medicine. Jamaica, USA: Spectrum Publ Inc, 1978:35-48.
93. Henkin RI, Law JS, Nelson NR. The role of zinc on the trophic growth factors nerve growth factor and gustin. In: Hurley LS, Keen CL, Lonnerdal B, Rucker RB, eds. Trace Elements in Man and Animals. New York: Plenum Press, 1988:385-388.
94. Law JS, Nelson NR, Watanabe K, Henkin RI. Human salivary gustin is a potent activator of calmodulin-dependent brain phosphodiesterase. Proc Natl Acad Sci USA 1987; 84:1674-1678.
95. Henkin RI, Patten BM, Re P, Bronzert DA. A syndrome of acute zinc loss. Arch Neurol 1975; 32:745-751.
96. Henkin RI, Schechter PJ, Hoye RC. Idiopathic hypogeusia with dysgeusia, hyposmia and dysosmia: a new syndrome. J Am Med Assoc 1971; 217:434-440.
97. Shatzman AR, Henkin RI. Gustin concentration changes relative to salivary zinc and taste in humans. Proc Natl Acad Sci USA 1981; 78:3867-3871.
98. Yoshida S, Endo S, Tomita H. A double blind study of therapeutic efficacy of zinc gluconate on taste disorder. Auris Nasus Larynx 1991; 18:153-161.
99. Henkin RI, Schechter PJ, Friedemold WT, Demets DL, Raff MS. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976; 272:285-299.
100. Persani L, Borgato S, Ramoli R, Asteria C, Pizzocavo A, Beck-Piccoz P. Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrimol Metab 1998; 83:2486-2492.
101. Henkin RI, Papathanassiu A. cAMP is present in human nasal mucus and may act as a growth factor for cells of the olfactory epithelium. FASEB J 2002; 16:A1153.
102. Henkin RI. US Patent No. 5,384,308. Composition and method for enhancing wound healing. US Patent Office, 1995.
103. Tesfaigzi J, Thʼng J, Hotchkiss JA, Harkema JR, Wright PS. A small proline-rich proline, SPRR1, is upregulated early during tobacco smoke-induced squamous metaplasia in rat nasal epithelium. Am J Resp Cell Mol Biol 1996; 14:478-486.
104. Tachibana M, Mouska H, Machino M, Tamimura F, Mizukohi O. Amylase secretion by nasal glands. An immunocytochemical study. Ann Otol Rhinol Laryngol 1986; 95:284-287.
105. Agarwal RP, Henkin RI. Metal binding characteristics of human salivary and porcine pancreatic amylase. J Biol Chem 1987; 262:2568-2575.
106. Douglas CWI. The binding of human salivary a-amylase by oral strains of streptococcal bacteria. Arch Oral Biol 1983; 28:567-573.
107. Gregory MR, Gregory WW, Bruns DE, Zakowski JJ. Amylase inhibits Neisseria gonorrhoeae by degrading starch in the growth medium. J Clin Microbiol 1983; 18:1366-1369.
108. Mellersh A, Clark A, Hafiz S. Inhibition of Neisseria gonorrhoeae by normal human saliva. Br J Vener Dis 1979; 55:20-23.
109. Agarwal RP, Henkin RI. RIA of human salivary amylase: cross-reactivity with human and porcine pancreatic amylase and other salivary proteins. Metabolism 1984; 33:797-807.
110. Rossen RD, Butler WT, Cate TR, Szwed CF, Couch RB. Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med 1965; 119:1169-1176.
111. Henkin RI, Martin BM. A magnesium protein found in human parotid saliva. FASEB J 1995; 9:452A.
112. Law JS, Henkin RI. Low parotid saliva calmodulin in patients with taste and smell dysfunction. Biochem Med Met Biol 1986; 36:118-124.
113. Pevsner J, Sklar PB, Snyder SH. Odorant-binding protein: localization to nasal glands and secretions. Proc Natl Acad Sci USA 1986; 83:4942-4946.
114. Pevsner J, Snyder SH. Odorant binding protein: odorant transport function in the vertibrate nasal epithelium. Chem Senses 1990; 15:217-222.
115. Lundberg JON, Weitzburg E, Nordvall SL, Kaydenstierna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome. Eur Respir J 1994; 7:1501-1504.
116. Alving K, Weitzburg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-1370.
117. Kreit JW, Gross KB, Moore TB, Lorenzen TJ, D’Arcy J, Eschenbacher WL. Ozone-induced changes in pulmonary function and bronchial responsiveness in asthmatics. J Appl Physiol 1989; 66:217-222.
118. Molech HL, Gallin JI. Neutrophils in human disease. New Engl J Med 1987; 317:687-694.
119. Baraniuk JN, Shizari T, Sabol M, Ali M, Underhill CB. Hyaluronan is excytosed from serous, but not mucous cells of human nasal and trachiobronchial submucosal glands. J Invest Med 1996; 44:47-52.
120. Okuda M. Migrating cells in the epithelium of allergic nasal mucosa. Rhinology 1988; 26(suppl 1):136.
121. Mygind N, Bisgaard H. Applied anatomy of the airways. In: Mygind N, Pipkorn U, Dahl R, eds. Rhinitis and Asthma: Similarities and Differences. Copenhagen:Munskgaard, 1990:21-37.
122. Denburg JA, Dolovich J, Harnish D. Basophil, mast cell and eosinophil growth and differentiation factors in human allergic disease. Clin Exp Allergy 1989; 19:249-254.
123. Glanville AR, Tazelaar HD, Theodore J et al. The distribution of MHC class I and II antigens on bronchial epithelium. Am Rev Respir Dis 1989; 139:330-334.
124. Kalb TH, Chuang MT, Marom I, Mayer L. Evidence for accessary cell function by class I MHC antigen expressing airway epithelial cells. Am J Respir Cell Mol Biol 1991; 4:320-329.
125. Butler WT, Waldman TA, Rossen RD, Douglas RG Jr, Couch RB. Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol 1970; 105:584-591.
126. Doyle WJ, Skoner DP, White M, Hayden F, Kaplan AP, Kaliner MA, Shibayama V, Fireman P. Pattern of nasal secretions during experimental virus infection. Rhinology 1996; 34:2-8.
127. Igarashi V, Skoner DP, Doyle WJ, White MV, Fireman P, Kaliner MA. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993; 92:722-731.
128. Kaliner MA. Human nasal respiratory secretions and host defense. Am Rev Respir Dis 1991; 144(suppl):52-56.
129. Raphael GD, Jeney EV, Baranick JN, Kim I, Meredith SD, Kaliner MA. Pathophysiology of rhinitis: lactoferrin and lysozyme in nasal secretion. J Clin Invest 1989; 84:1528-1535.
130. Lundgren JD, Shelhamer JH. Pathogenesis of airway mucus hypersecretion. J Allergy Clin Immunol 1990; 85:399-419.
131. Naclerio RM, Kagey-Sobotka A, Togias A et al. Nasal lavage: a technique for elucidating the pathophysiology of allergic rhinitis. In: Mygind N, Pipkorn U, Dahl R, eds. Rhinitis and Asthma: Similarities and Differences. Copenhagen:Munksgaard, 1990:213-221.
132. Persson CGA. Role of plasma exudation in asthmatic airway. Am Rev Respir Dis 1986; 133:1126-1129.
133. Persson CGA, Erjefalt I, Alkner U et al. Plasma exudation as a first line respiratory mucosal defense. Clin Exp Allergy 1991; 21:17-21.
134. Erjefalt A, Persson CGA. Inflammatory passage of plasma macromolecules into airway tissue and lumen. Pulm Pharmacol 1989; 2:93-102.
135. Persson CGA. Mucosal exudation mechanisms. Allergy Clin Immunol News 1991; 3:142-149.
136. Aitken ML, Verdugo P. Donnan mechanism of mucin release and conditioning. In:Chantler FN, ed. Goblet Cells: The Role of Polions in Mucus and Related Topics. New York: Plenum, 1989:1-8.
137. Gordon RE, Lane BP. Regeneration of rat tracheal epithelium after mechanical injury. II. Restoration of surface integrity during the early hours after injury. Am Rev Respir Dis 1976; 113:799-807.
138. Keenan KD, Combs JW, McDowell EM. Regeneration of hamster tracheal epithelium after mechanical injury. I. Focal lesions: quantitative morphologic study of cell proliferation. Virchows Arch (Cell Pathol) 1982; 41:193-214.
139. Marin ML, Gordon RE, Lane BP. Development of tight junctions in rat tracheal epithelium during the early hours after mechanical injury. Am Rev Respir Dis 1979; 119:101-106.
140. Zahm JM, Chevillard M, Pachelle E. Wound repair of human surface respiratory epithelium. Am J Respir Cell Mol Biol 1991; 5:242-248.
141. Lee CH, Rhee CS, Min YG, Oh SH, Lee MS. Increase in expression of IL-4 and IL-5 mRNA in the nasal mucosa of patients with perennial allergic rhinitis during natural allergen exposure. Ann Otol Rhinol Laryngol 1997; 106:215-219.
142. Saito H, Asakura K, Kataura A. Study on the IL-5 expression is allergic nasal mucosa. Int Arch Allergy Immunol 1994; 104(suppl 1):39-40.
143. Sim TC, Grant A, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994; 149:339-344.
144. Mandel ID. Defense of the oral cavity. In: Kleinberg I, Ellison SA, Mandel ID, eds. Saliva and Dental Caries. London: Information Retrieval Ltd, 1978:473-491.
145. Tabak L, Mandel ID, Baurmash H. Alterations in lactoferrin in salivary gland disease. J Dent Res 1978; 57:43-53.
146. Tabak L, Mandel ID, Herreru M, Baurmash H. Changes in lactoferrin and other proteins in a case of chronic recurrent parotitis. J Oral Pathol 1978; 7:91-99.
147. Bush RK, Yunginger JW. Standardization of fungal allergens. Clin Rev Allergy 1987; 5:3-21.
148. Deshazo RD, Chapin K, Swain RE. Fungal sinusitis. New Engl J Med 1997; 337:254-259.
149. Henkin RI. Drug induced taste and smell disorders: incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Safety 1994; 11:310-377.
150. Henkin RI, Talal N, Larson AL, Mattern CFT. Abnormalities of taste and smell in Sjögren’s syndrome. Ann Intern Med 1972; 76:375-383.
151. Kalmus H, Farnsworth D. Impairment and recovery of taste following irradiation of the nasopharynx. J Laryngol Otol 1959; 73:180-182.
152. MacCarthy-Levinthal EM. Post-radiation month blindness. Lancet 1959; 2:1138-1139.
153. Mossman KL, Henkin RI. Radiation induced changes in taste acuity in cancer patients. Int J Radiat Oncol Biol Phys 1978; 4:663-670.
154. Mossman KL, Chencharick JD, Scheer AC, Walker WP, Ornitz RD, Rogers CC, Henkin RI. Radiation-induced changes in gustatory function: comparision of effects of neuron and photon irradiation. Int J Radat Oncol Biol Phys 1979; 5:521-528.
155. Rubin R, Casarett G. Clinical Radiation Pathology. Vol. 1. Philadelphia, PA:Saunders, 1968:260-261.
156. Powell RD, Larson AL, Henkin RI. Nasal mucous membrane biopsy in Sjögren’s syndrome: a new diagnostic techinique. Ann Intern Med 1974; 81:25-31.
157. Bardana E, Montanero A. Sjögren’s syndrome: a rheumatic disorder with prominent respiratory manifestations. Ann Allergy 1990; 64:3-10.
158. Constantopoulos SH, Papadimitirou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjögren’s syndrome: a clinical, functional and histologic study. Chest 1985; 88:226-229.
159. Fairfax AJ, Haslam PL, Pavia P, Sheahan NF, Bateman JRN, Agnew JE, Clarke SW, Turner-Warwick M. Pulmonary disorders associated with Sjögren’s syndrome. Qu J Med 1981; 199:279-295.
160. Newball HH, Brahim SA. Chronic obstructive lung disease in patients with Sjögren’s syndrome. Am Rev Respir Dis 1977; 115:295-304.
161. Strimlan CV, Rosenow EC III, Divertie MB, Harrison EG. Pulmonary manifestations of Sjögren’s syndrome. Chest 1976; 70:354-361.
162. Shima H. Pulmonary function abnormalities and respiratory manifestations in Sjögren’s syndrome. Nippon Rinsha 1995; 53:16-20 (in Japanese, English Abstract).
163. Robinson DA, Meyer CF. Primary Sjögren’s syndrome associated with recurrent sinopulmonary infections and bronchiectasis. J Allergy Clin Immunol 1995; 94:263-264.
164. Deheinzelin D. Interstitial lung disease in primary Sjögren’s syndrome: clinical- pathological evaluation and response to treatment. Am J Resp Crit Care Med 1996; 154:794-799.
165. Kadota J, Kusano S, Kawakami K, Morikawa T, Kohno S. Usual interstitial pneumonia associated with primary Sjögren’s syndrome. Chest 1995; 98:1756-1758.
166. Hatron PY, Wallaert B, Gosset AB, Tonnel B, Gosselin B, Voisin C, Devulder B. Subclinical lung inflammation in primary Sjögren’s syndrome: relationship between findings and characteristics of the disease. Arthritis Rheum 1987; 30:1226-1231.
167. Matterson EL, Ike RW. Bronchiolitis obliterans organizing pneumonia and Sjögren’s syndrome. J Rheumatol 1990; 17:676-679.
168. Usui Y, Kimula Y, Miura H, Kodaira Y, Takayama S, Nakamura M, Kataoka N. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjögren’s syndrome who died of superimposed diffuse alveolar damage. Respiration 1992; 59:122-124.
169. Simms RW, Kirby RE. A 64 year old man with cranial-nerve palsies and a positive test for antinuclear cytoplasmic antibodies. N Engl J Med 1998; 339:755-764.
170. Fauci AS, Haynes BF, Katz P, Wolff S. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
171. McDonald TJ, DeRemee RA. Head and neck involvement in Wegener’s granulomatosis (WG). Adv Exp Med Biol 1993; 336:309-313.
172. BoehringerIngelheim. Atrovent (ipratropiun bromide) nasal spray. Physicians Desk Ref 1998; 52:708-709.
173. Edward DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzer J, Deaner D, Lotan N, Langer R. Large porous paticles for pulmonary drug delivery. Science 1997; 276:1868-1871.